Business Description
Staar Surgical Co
NAICS : 339115
SIC : 3851
ISIN : US8523123052
Share Class Description:
STAA: Ordinary SharesTotal Employee Number:
957Description
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.4 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 2.53 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 9.13 | |||||
Beneish M-Score | -0.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 17.23 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.46 | |||||
9-Day RSI | 38.41 | |||||
14-Day RSI | 42.95 | |||||
3-1 Month Momentum % | 40.97 | |||||
6-1 Month Momentum % | 20.72 | |||||
12-1 Month Momentum % | 62.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.12 | |||||
Quick Ratio | 4.31 | |||||
Cash Ratio | 2.69 | |||||
Days Inventory | 282.67 | |||||
Days Sales Outstanding | 66.8 | |||||
Days Payable | 57.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 0.56 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.89 | |||||
Operating Margin % | 2.13 | |||||
Net Margin % | -7.24 | |||||
EBITDA Margin % | 5.08 | |||||
FCF Margin % | -18.94 | |||||
OCF Margin % | -17.28 | |||||
ROE % | -6.05 | |||||
ROA % | -4.66 | |||||
ROIC % | 2.69 | |||||
3-Year ROIIC % | -151.57 | |||||
ROC (Joel Greenblatt) % | 3.79 | |||||
ROCE % | 1.6 | |||||
Years of Profitability over Past 10-Year | 6 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 99.55 | |||||
PE Ratio without NRI | 433.98 | |||||
Shiller PE Ratio | 686.04 | |||||
PS Ratio | 4.82 | |||||
PB Ratio | 3.92 | |||||
Price-to-Tangible-Book | 4.37 | |||||
EV-to-EBIT | 202.94 | |||||
EV-to-EBITDA | 85.26 | |||||
EV-to-Forward-EBITDA | 45.43 | |||||
EV-to-Revenue | 4.33 | |||||
EV-to-Forward-Revenue | 3.91 | |||||
EV-to-FCF | -22.86 | |||||
Price-to-GF-Value | 0.88 | |||||
Price-to-Projected-FCF | 5.44 | |||||
Price-to-Median-PS-Value | 0.54 | |||||
Price-to-Graham-Number | 9.2 | |||||
| Price-to-Net-Current-Asset-Value | 6.47 | |||||
| Price-to-Net-Cash | 21.2 | |||||
Earnings Yield (Greenblatt) % | 0.49 | |||||
FCF Yield % | -3.97 | |||||
Forward Rate of Return (Yacktman) % | 20.98 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:STAA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Staar Surgical Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 290.375 | ||
| EPS (TTM) ($) | -0.43 | ||
| Beta | 1.1492 | ||
| 3-Year Sharpe Ratio | -0.14 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 72.41 | ||
| 14-Day RSI | 42.95 | ||
| 14-Day ATR ($) | 1.239306 | ||
| 20-Day SMA ($) | 29.124 | ||
| 12-1 Month Momentum % | 62.24 | ||
| 52-Week Range ($) | 15.585 - 35.87 | ||
| Shares Outstanding (Mil) | 49.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Staar Surgical Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Staar Surgical Co Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-05 | In 122 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 16:30 | In 32 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 31 days | ||
| General meeting for 2026 | 2026-06-18 08:30 | 29.22 (+1.35%) | ||
| Canaccord Genuity Virtual Fireside Chat | 2026-05-27 14:30 | 33.34 (+1.12%) | ||
| Guidance call for 2026 | 2026-05-26 16:30 | 32.47 (-0.76%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 17:30 | 28.18 (+1.18%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 28.18 (+1.18%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-03 17:30 | 19.05 (-2.46%) | ||
| Annual report for 2025 | 2026-03-03 | 19.05 (-2.46%) |
Show
Entries
Staar Surgical Co Frequently Asked Questions
What is Staar Surgical Co(STAA)'s stock price today?
The current price of STAA is $27.78. The 52 week high of STAA is $35.87 and 52 week low is $15.59.
When is next earnings date of Staar Surgical Co(STAA)?
The next earnings date of Staar Surgical Co(STAA) is 2026-08-06 Est..
Does Staar Surgical Co(STAA) pay dividends? If so, how much?
Staar Surgical Co(STAA) does not pay dividend.
Guru Commentaries on NAS:STAA
No articles.
Press Release
Articles on Staar Surgical Co
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers